Logo image of OB

OUTBRAIN INC (OB) Stock Fundamental Analysis

NASDAQ:OB - Nasdaq - US69002R1032 - Common Stock - Currency: USD

2.74  -0.07 (-2.49%)

After market: 2.8 +0.06 (+2.19%)

Fundamental Rating

3

Overall OB gets a fundamental rating of 3 out of 10. We evaluated OB against 70 industry peers in the Interactive Media & Services industry. OB has a bad profitability rating. Also its financial health evaluation is rather negative. OB has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year OB has reported negative net income.
In the past year OB had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: OB reported negative net income in multiple years.
In the past 5 years OB always reported a positive cash flow from operatings.
OB Yearly Net Income VS EBIT VS OCF VS FCFOB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

OB's Return On Assets of -2.99% is in line compared to the rest of the industry. OB outperforms 49.30% of its industry peers.
Looking at the Return On Equity, with a value of -10.64%, OB is in line with its industry, outperforming 46.48% of the companies in the same industry.
Industry RankSector Rank
ROA -2.99%
ROE -10.64%
ROIC N/A
ROA(3y)-0.58%
ROA(5y)0.02%
ROE(3y)-2.34%
ROE(5y)-0.13%
ROIC(3y)N/A
ROIC(5y)N/A
OB Yearly ROA, ROE, ROICOB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

With a Gross Margin value of 24.31%, OB is not doing good in the industry: 84.51% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of OB has remained more or less at the same level.
OB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y0.91%
OB Yearly Profit, Operating, Gross MarginsOB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 5 10 15 20

More info and screens

3

2. Health

2.1 Basic Checks

OB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OB has been increased compared to 1 year ago.
OB has less shares outstanding than it did 5 years ago.
There is no outstanding debt for OB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
OB Yearly Shares OutstandingOB Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
OB Yearly Total Debt VS Total AssetsOB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 0.50, we must say that OB is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.50, OB is in line with its industry, outperforming 42.25% of the companies in the same industry.
The Debt to FCF ratio of OB is 15.66, which is on the high side as it means it would take OB, 15.66 years of fcf income to pay off all of its debts.
OB has a Debt to FCF ratio of 15.66. This is comparable to the rest of the industry: OB outperforms 52.11% of its industry peers.
A Debt/Equity ratio of 1.32 is on the high side and indicates that OB has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.32, OB is doing worse than 80.28% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF 15.66
Altman-Z 0.5
ROIC/WACCN/A
WACC8.68%
OB Yearly LT Debt VS Equity VS FCFOB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

OB has a Current Ratio of 1.13. This is a normal value and indicates that OB is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of OB (1.13) is worse than 76.06% of its industry peers.
OB has a Quick Ratio of 1.13. This is a normal value and indicates that OB is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of OB (1.13) is worse than 76.06% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.13
OB Yearly Current Assets VS Current LiabilitesOB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

4

3. Growth

3.1 Past

OB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.00%, which is quite impressive.
The Revenue has been growing slightly by 4.16% in the past year.
Measured over the past years, OB shows a small growth in Revenue. The Revenue has been growing by 5.30% on average per year.
EPS 1Y (TTM)25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)4.16%
Revenue growth 3Y-4.31%
Revenue growth 5Y5.3%
Sales Q2Q%31.98%

3.2 Future

The Earnings Per Share is expected to grow by 101.45% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 7.84% on average over the next years.
EPS Next Y977.64%
EPS Next 2Y355.64%
EPS Next 3Y101.45%
EPS Next 5YN/A
Revenue Next Year59.77%
Revenue Next 2Y29.71%
Revenue Next 3Y7.84%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OB Yearly Revenue VS EstimatesOB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
OB Yearly EPS VS EstimatesOB Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6 0.8

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OB. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 3.30, which indicates a rather cheap valuation of OB.
Based on the Price/Forward Earnings ratio, OB is valued cheaper than 100.00% of the companies in the same industry.
OB's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.70.
Industry RankSector Rank
PE N/A
Fwd PE 3.3
OB Price Earnings VS Forward Price EarningsOB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, OB is valued cheaply inside the industry as 94.37% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.45
EV/EBITDA N/A
OB Per share dataOB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as OB's earnings are expected to grow with 101.45% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y355.64%
EPS Next 3Y101.45%

More info and screens

0

5. Dividend

5.1 Amount

OB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OUTBRAIN INC

NASDAQ:OB (6/9/2025, 8:00:02 PM)

After market: 2.8 +0.06 (+2.19%)

2.74

-0.07 (-2.49%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-06 2025-08-06
Inst OwnersN/A
Inst Owner Change17.93%
Ins OwnersN/A
Ins Owner Change1.91%
Market Cap258.38M
Analysts78.46
Price Target5.44 (98.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-60.21%
Min EPS beat(2)-102.79%
Max EPS beat(2)-17.62%
EPS beat(4)2
Avg EPS beat(4)50.06%
Min EPS beat(4)-102.79%
Max EPS beat(4)284.85%
EPS beat(8)5
Avg EPS beat(8)515.51%
EPS beat(12)7
Avg EPS beat(12)306.55%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.58%
Min Revenue beat(2)-8.54%
Max Revenue beat(2)-0.62%
Revenue beat(4)0
Avg Revenue beat(4)-5.74%
Min Revenue beat(4)-9.09%
Max Revenue beat(4)-0.62%
Revenue beat(8)0
Avg Revenue beat(8)-5.76%
Revenue beat(12)2
Avg Revenue beat(12)-3.42%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.42%
PT rev (3m)-35%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-180.1%
EPS NY rev (1m)0%
EPS NY rev (3m)-12.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.31%
Revenue NY rev (1m)-0.27%
Revenue NY rev (3m)28.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.3
P/S 0.27
P/FCF 6.45
P/OCF 4.38
P/B 0.54
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)0.83
Fwd EY30.31%
FCF(TTM)0.42
FCFY15.5%
OCF(TTM)0.63
OCFY22.83%
SpS10.17
BVpS5.03
TBVpS-5.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.99%
ROE -10.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.31%
FCFM 4.17%
ROA(3y)-0.58%
ROA(5y)0.02%
ROE(3y)-2.34%
ROE(5y)-0.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y0.91%
F-Score4
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF 15.66
Debt/EBITDA N/A
Cap/Depr 69.03%
Cap/Sales 1.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 1.13
Altman-Z 0.5
F-Score4
WACC8.68%
ROIC/WACCN/A
Cap/Depr(3y)94.29%
Cap/Depr(5y)88.52%
Cap/Sales(3y)2.24%
Cap/Sales(5y)2.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y977.64%
EPS Next 2Y355.64%
EPS Next 3Y101.45%
EPS Next 5YN/A
Revenue 1Y (TTM)4.16%
Revenue growth 3Y-4.31%
Revenue growth 5Y5.3%
Sales Q2Q%31.98%
Revenue Next Year59.77%
Revenue Next 2Y29.71%
Revenue Next 3Y7.84%
Revenue Next 5YN/A
EBIT growth 1Y-360.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3702.14%
EBIT Next 3Y261.82%
EBIT Next 5YN/A
FCF growth 1Y199.3%
FCF growth 3Y11.78%
FCF growth 5Y51.85%
OCF growth 1Y520.46%
OCF growth 3Y6.5%
OCF growth 5Y32.58%